Abstract

Systemic or oral administration of arginine improves the function of cardiovascular system and reduces myocardial ischemia in patients with coronary heart disease, lowers blood pressure in hypertensive patients and in patients with normal or poor kidney function. Although the concentration of arginine in the plasma do not vary with hypercholesterolemia, oral or intravenous administration of arginine can significantly reduce endothelial dysfunction in patients with hypercholesterolemia and in smokers. The main action Arginina due to its role as a precursor of nitric oxide synthesis. L-arginine affects the pathophysiological mechanisms that exist method, the progression of atherosclerosis. L-arginine can be considered as an integrative part of a multimodal approach to combating acute cerebrovascular pathology, development-it excitotoxicity and ischemic brain injury. Neuroprotective properties of the L-arginine suggests that they may have potential as neuroprotective therapy in stroke patients.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.